Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Autophagy ; 12(7): 1168-79, 2016 07 02.
Artigo em Inglês | MEDLINE | ID: mdl-27171858

RESUMO

Searching for new regulators of autophagy involved in selective dopaminergic (DA) neuron loss is a hallmark in the pathogenesis of Parkinson disease (PD). We here report that an endoplasmic reticulum (ER)-associated transmembrane protein SLC35D3 is selectively expressed in subsets of midbrain DA neurons in about 10% TH (tyrosine hydroxylase)-positive neurons in the substantia nigra pars compacta (SNc) and in about 22% TH-positive neurons in the ventral tegmental area (VTA). Loss of SLC35D3 in ros (roswell mutant) mice showed a reduction of 11.9% DA neurons in the SNc and 15.5% DA neuron loss in the VTA with impaired autophagy. We determined that SLC35D3 enhanced the formation of the BECN1-ATG14-PIK3C3 complex to induce autophagy. These results suggest that SLC35D3 is a new regulator of tissue-specific autophagy and plays an important role in the increased autophagic activity required for the survival of subsets of DA neurons.


Assuntos
Proteínas Relacionadas à Autofagia/metabolismo , Autofagia/fisiologia , Proteína Beclina-1/metabolismo , Neurônios Dopaminérgicos/metabolismo , Mesencéfalo/metabolismo , Proteínas de Transporte de Monossacarídeos/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Animais , Classe III de Fosfatidilinositol 3-Quinases , Dopamina/metabolismo , Camundongos Knockout , Degeneração Neural/patologia , Tirosina 3-Mono-Oxigenase/metabolismo , Área Tegmentar Ventral/metabolismo
2.
PLoS Genet ; 10(2): e1004124, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24550737

RESUMO

Obesity is one of the largest health problems facing the world today. Although twin and family studies suggest about two-thirds of obesity is caused by genetic factors, only a small fraction of this variance has been unraveled. There are still large numbers of genes to be identified that cause variations in body fatness and the associated diseases encompassed in the metabolic syndrome (MetS). A locus near a sequence tagged site (STS) marker D6S1009 has been linked to obesity or body mass index (BMI). However, its genetic entity is unknown. D6S1009 is located in the intergenic region between SLC35D3 and NHEG1. Here we report that the ros mutant mice harboring a recessive mutation in the Slc35d3 gene show obesity and MetS and reduced membrane dopamine receptor D1 (D1R) with impaired dopamine signaling in striatal neurons. SLC35D3 is localized to both endoplasmic reticulum (ER) and early endosomes and interacts with D1R. In ros striatal D1 neurons, lack of SLC35D3 causes the accumulation of D1R on the ER to impair its ER exit. The MetS phenotype is reversible by the administration of D1R agonist to the ros mutant. In addition, we identified two mutations in the SLC35D3 gene in patients with MetS, which alter the subcellular localization of SLC35D3. Our results suggest that the SLC35D3 gene, close to the D6S1009 locus, is a candidate gene for MetS, which is involved in metabolic control in the central nervous system by regulating dopamine signaling.


Assuntos
Dopamina/genética , Síndrome Metabólica/genética , Proteínas de Transporte de Monossacarídeos/genética , Obesidade/genética , Animais , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/patologia , Dopamina/metabolismo , Feminino , Humanos , Masculino , Síndrome Metabólica/metabolismo , Síndrome Metabólica/patologia , Camundongos , Proteínas de Transporte de Monossacarídeos/metabolismo , Mutação , Neurônios/metabolismo , Neurônios/patologia , Obesidade/metabolismo , Obesidade/patologia , Receptores de Dopamina D1/genética , Receptores de Dopamina D1/metabolismo , Transdução de Sinais , Córtex Visual/metabolismo , Córtex Visual/patologia
3.
Yi Chuan ; 30(7): 831-7, 2008 Jul.
Artigo em Chinês | MEDLINE | ID: mdl-18779124

RESUMO

MnSOD, which is an important oxygen free radical scavenger in organisms, has an effect to resist oxidative stress and tumor. The expression and regulation of MnSOD gene is a complicated process, which includes many kinds of transcription factors, cell signal molecules and cell signal pathways. It refers to three aspects including transcription regulation, post-transcription regulation and translation regulation. Transcription regulation is the primary step for MnSOD gene expression and plays a key role during the expression of MnSOD gene. The activity of transcription factors, which controls MnSOD gene expression, such as SP-1, AP-2, AP-1, NF-kB and so on, can be changed in the course of transcription regulation. Drugs and metalions can also affect those transcription factors' activity. Furthermore some genes mutation and depletion also have an influence on the activity of those transcription factors. Post-transcription regulation is in a way of changing the stability of mRNA and its translation. Translation regulation is a process to regulate edition, modification, binding to metalion and site-specific of MnSOD polypeptide. Recently a kind of manganese trafficking factor for mitochondrial MnSOD called MTMl which is very important for activation of MnSOD has been discovered. Here, we review the advances in this field with an emphasis on transcription regulation and translation regulation of MnSOD gene. And at last, we discussed the prospect of MnSOD gene expression and regulation.


Assuntos
Regulação da Expressão Gênica , Superóxido Dismutase/genética , Animais , Humanos , NF-kappa B/metabolismo , Transdução de Sinais/genética , Transdução de Sinais/fisiologia , Transcrição Gênica/genética , Transcrição Gênica/fisiologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA